Recent advances in breast cancer treatmentISSN: 1465-542X (Online) In this topical collection (7 articles) Review uPA and PAI-1 as biomarkers in breast cancer: validated for clinical use in level-of-evidence-1 studies Michael J Duffy, Patricia M McGowan, Nadia Harbeck… Article:428 ...
Open Access ArticlesResearch Article Increased SLC7A3 Expression Inhibits Tumor Cell Proliferation and Predicts a Favorable Prognosis in Breast CancerPp: 55-70 Volume: 20, Issue: 1 Authors: Lifang He, Yue Xu, Jiediao Lin, Stanley Li Lin* and Yukun Cui* ...
Unprecedented declines in invasive breast cancer rates occurred in the United States between 2001 and 2004, particularly for estrogen receptor-positive tumors among non-Hispanic white women over 50 years. To understand the broader public health import of these reductions among previously unstudied populati...
As our understanding of the biology of breast cancer continues to improve, treatment of the disease continues to change. Although the ultimate goal of treatment remains improved survival, increasing emphasis is now put on less morbid treatments and improving quality of life. Prevention remains a ...
nearly 19.3 million new cancer cases and approximately 10 million cancer-related deaths are expected by 2020. The five most commonly diagnosed cancers are female breast cancer (11.7%), lung cancer (11.4%), colorectal cancer (10%), prostate cancer (PC; 7.3%), and stomach cancer (5.6%) [2...
(cytosensor), which captured breast cancer cells (MCF7) with high EpCAM expression by creating three-dimensional bionic interfaces and cross-linking long nanofibers (glycolic acid-lactic acid) (PLGA) to the surface of Ni micropolar using an electrospinning method. Afterwards, through the use of ...
Breast cancer is the most common malignancy in women all over the world. Genetic background of women contributes to her risk of having breast cancer. Certain inherited DNA mutations can dramatically increase the risk of developing certain cancers and are
Ascertainment of Incident Invasive Cancer Types We identified incident invasive cancer types (excluding nonmelanoma skin cancer, in situ breast cancer, and stage T1a prostate cancer) via participants’ biennial self-report or regular searches of death certificates identified using the National Death Index...
OPEN REVIEW Journal of Human Genetics (2017) 62, 15–24 Official journal of the Japan Society of Human Genetics www.nature.com/jhg Recent trends in microRNA research into breast cancer with particular focus on the associations between microRNAs and intrinsic subtypes Sasagu Kurozumi1,2, Yuri ...
nearly 19.3 million new cancer cases and approximately 10 million cancer-related deaths are expected by 2020. The five most commonly diagnosed cancers are female breast cancer (11.7%), lung cancer (11.4%), colorectal cancer (10%), prostate cancer (PC; 7.3%), and stomach cancer (5.6%) [2...